Unexplained weight loss (UWL), defined as a decrease of 5% or more in body weight over a period of 6 to 12 months without a clear cause, poses a significant diagnostic challenge in clinical practice. This article aims to provide a comprehensive approach to the evaluation and management of UWL.
UWL can be the result of a variety of underlying conditions, including gastrointestinal diseases, malignancies, endocrine disorders, mental health conditions, and infectious diseases. It can also be a side effect of certain medications. A thorough history and physical examination are crucial in identifying potential causes.
A stepwise approach is recommended for the evaluation of UWL. Initial investigations should include a comprehensive metabolic panel, complete blood count, thyroid function tests, and urinalysis. If these tests are inconclusive, further investigations such as imaging studies, endoscopy, or biopsy may be warranted based on the patient's symptoms and risk factors.
Management of UWL primarily involves treating the underlying condition. In cases where no clear cause is identified, a symptom-focused approach may be beneficial. This may include nutritional support, medication review, and psychological interventions. Regular follow-up is essential to monitor the patient's progress and reassess the diagnosis if necessary.
While UWL can be a perplexing diagnostic dilemma, a systematic and comprehensive approach can aid in the identification and management of the underlying cause. It is crucial for healthcare professionals to consider a broad differential diagnosis and to utilize appropriate diagnostic tools in a stepwise manner. Regular patient follow-up and reassessment are key in ensuring effective management and positive patient outcomes.
1.
Can Prior Authorization Be Better With Artificial Intelligence?
2.
How a California Oncologist Making $850k Spends Money
3.
DNA's hidden shape reveals target to reverse ovarian cancer chemoresistance
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.
1.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
2.
Uncovering the Mysteries of Breast Cancer: The Journey to a Cure
3.
Erythropoiesis Modulation in Chronic Anemia Management
4.
Comprehensive Concepts in Oncology in Clinical Decision-Making
5.
Precision Cancer Risk Mitigation Strategies
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
3.
Managing Supportive Care During Platelet Recovery
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation